Quality of Life and Long-Term Mortality in Patients with Advanced Chronic Heart Failure Treated with Intermittent Low-Dose Intravenous Inotropes in an Outpatient Setting

Abstract

In patients with advanced refractory HF symptoms, treatment with low-dose, intermittent intravenous inotropes in an outpatient setting is associated with significant improvement in QOL. However, improvement in QOL in this population does not appear to affect subsequent long-term survival.